DONATE

Next-Generation Nanomedicine (NET-NANO) 

Description

Nanomedicine represents a paradigm shift in healthcare, offering tailored and sophisticated diagnostic, imaging, and therapeutic solutions for unmet medical needs. This network unites an interdisciplinary team of 9 IBEC groups, fostering new collaborations to drive translational research with far-reaching societal implications. For this, 4 workshops will be held, covering basic and applied research: will address challenges and new models to bridge in vitro-to-in vivo and bench-to-clinic gaps. Talks and onsite discussions will ignite ideas, supported by a Teams channel to enable continued contact and lead to project proposals that will be pitched and evaluated in the final retreat. 

NET-NANO counts on the participation of the following IBEC research groups:

Contact us:

Iris Batalha: ibatalha@ibecbarcelona.eu

Network Members

Network Coordinator

Iris Batalha

Senior Researcher

She works on developing nanomedicines that target cells through their metabolic phenotypes. 

    
Network Representatives:  

Anna Lagunas

CIBER-BBN Senior Researcher

She works on the interrogation of cells at the nanoscale to gather information on the spatio-temporal regulation of complex biological mechanisms.  

Juan Fraire

Senior Researcher

He works on exploring the synergy between nanocarriers, advanced light-triggered effects, and cutting-edge enzymatic nanomotors.

Núria Blanco-Cabra

Postdoctoral researcher

She works on innovative antibiofilm therapies, including the use of nanomedicine to target and cross bacterial biofilms.

Silvia Muro

Group Leader

She works on the design of nanodevices for delivery of therapeutics to specific disease sites. 

Galyna Malieieva

Senior researcher

She works on the development of new light-activatable nanoswitches for the control of neuronal activity with nanoscale precision for brain circuits studies and innovative neurotherapeutic strategies.  

Adriano Caliari

Postdoctoral Researcher

He works on the introduction of specific receptors on xenobiotic membranes to trigger artificial phagocytosis. 

Mamatha Nijaguna

Postdoctoral Researcher

She works on the identification of mechanoinhibitors with potential therapeutic applications.  

Annalisa Calò

Senior Researcher

She works on the transformations and nanoscale properties of different functional nanomaterials and on the biophysical characterization of biological entities by scanning probe techniques. 

Network Programme

NET-NANO will organize 4 half-day workshops (WS) and a final retreat. Each workshop will feature two distinguished national or international experts and five IBEC speakers. Each WS will feature a «Challenge Board» to help ignite ideas and interactions, and to provide attendees with a platform to discuss and foster collaboration among groups and with external speakers.  

Workshop Topics. Speakers and dates to be confirmed.  

  • WS1 – “Tools to study biological systems” will cover tools (imaging techniques, nanopatterned substrates, functionalized particles) to study biomechanics, cell behaviour, and signalling, relevant to understanding disease.  
  •  WS2 – “Selective targeting and biological barriers” will focus on ways to deliver therapies to otherwise inaccessible sites (BBB, lungs, biofilms). 
  • WS3 – “Emerging nanotherapeutic modalities” will explore self-adaptive, stimuli-responsive, and immunomodulatory strategies 
  • WS4 – “Towards clinical translation” will address challenges and new models to bridge in vitro-to-in vivo and bench-to-clinic gaps 

Final retreat: the aim is to select the final project and to discuss on future directions to foster continued collaboration beyond the original network scope. 

All IBEC groups are welcome to join the network and actively participate by sharing their insights.